Vol. 2 Núm. 82: Edición especial COVID-19 Abril-Diciembre 2020
-
3
-
2
-
1
-
1
Editorial
Edición especial COVID-19
Frente a la pandemia por COVID-19, el personal de salud enfrenta muchos retos, en virtud de la situación inédita que se les presenta. La celeridad del avance de la pandemia originó un caos inicial para responder a la emergencia, que ocasionó un problema de salud pública de gran magnitud, produciendo en todos los ámbitos temor ante lo desconocido. Paulatinamente su han despejado incógnitas preventivas, epidemiológicas, clínicas diagnósticas y terapéuticas que permiten paliar la situación, aunque aún la misma, se mantiene lejos del control como lo demuestran las cifras de afectación en todas partes del mundo.
Cada día diferentes grupos de trabajo comparten sus experiencias a través de publicaciones que permiten ir ordenando las evidencias que se generan en torno a esta novel enfermedad, siendo muy difícil para los médicos seguir el ritmo de estos avances científicos.
Es por ello que este número de Vitae lo hemos...
Vol. 2 Núm. 82: Edición especial COVID-19 Abril-Diciembre 2020
Publicado: 26-12-2020
Artículos originales
Breaking Down COVID-19
A Living Textbook Publication of First Medicine and Global Clinical Partners
The world is amidst a pandemic that is presenting one of the greatest public health challenges of the twenty-first century. A new coronavirus has jumped the interspecies barrier, and it possesses the capability of efficient person-to-person...
Protocolo de Iberoamerican Research Network y la Federación Mexicana de Colegios de Obstetricia y Ginecología para SARS-CoV2 y embarazo
Actualización de la evidencia en: control prenatal, tratamiento, prevención y vacunación
La atención obstétrica en el contexto de COVID-19 debe sustentarse con las mejores prácticas clínicas y la evidencia científica disponible más reciente, por lo tanto, el desarrollo de recomendaciones debe estar relacionadas con la investigación...
COVID-19 update: The race to therapeutic development
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents
an unprecedented challenge to global public health. At the time of this review, COVID-19 has been diagnosed in
over 40 million...
COVID-19: Discovery, diagnostics and drug development
Coronavirus disease 2019 (COVID-19) started as an epidemic in Wuhan in 2019, and has since become a pandemic. Groups from China identified and sequenced the virus responsible for COVID-19, named severe acute respiratory syndrome coronavirus 2...
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature
Can a patient diagnosed with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) be infected again? This question is still unsolved. We tried to analyze local and literature cases with a positive respiratory swab after recovery. We...
Revista de Obstetricia y Ginecología de Venezuela
Volumen 80 Nro. 4 Año 2020: COVID-19, vacunas y embarazo. Dra. Mireya González Blanco. Directora/Editora
Trabajos originales
Desempeño del índice proteína/creatinina para predecir proteinuria...
Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review
Background: In the context of the COVID-19 worldwide pandemic, an up-to-date review of current challenges in addictions is necessary. While large scale disasters may have an impact on substance use and addictions, the use of some substances is...
Towards a more effective strategy for COVID‑19 prevention (Review)
At the end of 2019, a new disease, similar to severe acute respiratory syndrome (SARS) associated with SARS‑CoV was reported in Wuhan, China. It was quickly discovered that the etiological factor of the new disease (COVID‑19) was a previously...
Extremely low prevalence of asymptomatic COVID-19 among healthcare workers caring for COVID-19 patients in Israeli hospitals: a cross-sectional study
Objectives: We aimed to compare the prevalence of asymptomatic coronavirus disease 19 (COVID-19) among clinical staff in designated COVID-19 units versus that among staff in similar units with no known or suspected COVID-19...
COVID-19 and the heart: An update for clinicians
SARS-CoV-2, the cause of the COVID-19 pandemic has significantly impacted cardiovascular healthcare. Patients with pre-existing cardiovascular disease are at higher risk of morbidity and mortality. The virus may affect the heart directly and...
De interés
Obesity a predictor of outcomes of COVID‐19 hospitalized patients - A systematic review and meta‐analysis
Coronavirus disease 2019 (COVID‐19) pandemic is a global health crisis. Very few studies have reported association between obesity and severity of COVID‐19. In this meta‐analysis, we assessed the association of obesity and outcomes in COVID‐ 19...
Salud hoy
COVID-19 diagnosis - A review of current methods
A fast and accurate self-testing tool for COVID-19 diagnosis has become a prerequisite to comprehend the exact number of cases worldwide and to take medical and governmental actions accordingly. SARS-CoV-2 (formerly, 2019-nCoV) infection was...
COVID-19 Disease and Ophthalmology: An Update
The worldwide outbreak of the severe and acute respiratory coronavirus disease (COVID-19) caused by the coronavirus strain SARS-CoV-2 is currently the focal point of discussion due to the suffering this syndrome is causing to...
Telemedicina
COVID-19 and diabetes. Possible role of polymorphism and rise of telemedicine
Background: Diabetes has been found to be one of the leading comorbidities associated with fatality in COVID-19 patients. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry is facilitated by interaction with...

